Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Torrent pharmaceuticals ltd. by sushain mahajan to tafheen si rpptx

737 views

Published on

torrent pharma

Published in: Business
  • Be the first to comment

  • Be the first to like this

Torrent pharmaceuticals ltd. by sushain mahajan to tafheen si rpptx

  1. 1. TORRENT PHARMACEUTICALS LTD. Business Statistics and Quantitative Technique Submission to : Mr. Tafheem Submission by : Sushain Mahajan MBA (PM), 2nd Semester
  2. 2. INDEX  Introduction.  History.  Mission , Vision and Values.  List of API’s Manufactured.  Analysis of Profits with specific calculations using business statistics.
  3. 3. INTRODUCTION OF COMPANY:  Torrent Pharma is in the Pharmaceuticals sector.  Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group.  Based in Ahmedabad , it was promoted by U. N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name Torrent Pharmaceuticals Ltd.  Torrent Pharmaceuticals operates in more than 50 countries with over 1000 product registrations globally.  The current market capitalisation stands at Rs 21,510.75 crore.
  4. 4. COMPANY MANAGEMENT INCLUDES: • Ashish Nanda, • Bhavna Doshi • Samir Mehra • Markand Bhatt, • Pradeep Bhargava, • Shailesh Haribhakti • Sudhir Mehta Chairman Director Independ ent Director Executive Vice Chairman
  5. 5. HISTORY:  1972 - The Company was incorporated on 15th July, as a Private Limited Company by Shri Rajnikant C. Patel and his family members, and in June 1982, the company was acquired by Shri Uttamlal N. Mehta.  1989 - On 28th June the Company became a deemed Public Company under the provisions of Section 43-A of the Act and by a Special Resolution passed on 25th July, 1992 at the Annual General Meeting, the Company became a Public Limited Company within the meaning of Section 3(1)(iv) of the act and adopted a new set of articles.  1992 - Torrent Laboratories Limited, was amalgamated with the Company with effect from 1st April by an order of the Honourable High Court of Gujarat, dated 22nd December.  1993 - The Company proposes to modernize its present manufacturing facilities located at Vatva and Chhatral to conform to the GMP requirements as also to incorporate the latest technology available in the field.
  6. 6.  During the year, Torrent Medi-Systems Limited (TMSL) was merged with the Company with effect from 1st April consequent to the scheme of amalgamation approved by the Honourable High Court of Gujarat.  1994 - The Company issued 1,74,144 Equity Shares of Rs.10 each as fully paid up shares to the shareholders of TMSL after cancelling 9,300 Shares held by the Company in TMSL.  The Company was the first to launch ranitidine (Ranitin), nifedipine (Calcigard,) atenolol (Betacard), domperidone (Domstal), diltiazem (Dilzem), amiodorane (Cordarone), Lisinopril (Listril), etc. in the Indian market.  During the year the Company launched a number of new products like Zirtin, Tyklid, Flutamide and Topcef, all of which were well received in the market place.  1995 - During the year the Company launched a number of new products like Lomef (Lomefloxacin), Dilzem Inj. (Diltiazem), Depidol LA (Haliiperidiil Decanoate) Oncoden (Ondancetron), Nimotide (Nimodipne), Pefcin (Pefloxacin) which have gained wide acceptance in the pharmaceutical market.
  7. 7.  1999 - Among the new products launched recently included Nikoran IV for critical care in cardiology and a novel drug approved for launch in the anti- epileptic category.  2002 - Torrent Pharma’s manufacturing facilities certified with ISO 14001:1996.  Torrent’s R&D Centre received ISO/IEC 17025:1999 for its facilities by National Accreditation Board for Testing and Calibration Laboratories (NABL).  2003 - Torrent Pharma sets up a wholly owned subsidiaries in Germany and Brazil.  2004 - Torrent Pharmaceuticals Limited (TPL) has signed a non-exclusive agreement with Dr. Reddy's Laboratories Limited (DRL) for licensing and supplying the formulation of one of Torrent's blockbuster drug 'Domstal O' in the Gastro Intestinal segment
  8. 8.  2005 - Torrent Pharmaceuticals signs agreement with Novo Nordisk, Denmark to establish new, dedicated formulation and packaging facility for Insulin, exclusively for Novo Nordisk.  2006 - Torrent Pharma Receives USFDA Approval. Torrent’s Azuca launches 2 new blockbusters, Pregeb and Piopod.  2010 - The Board has recommended a dividend of Rs. 6.00 per equity share having face value of Rs. 5/- each.  2012 - The Board has appointed Haigreve khaitan as Additional Director.  The Board has recommended a final dividend of Rs. 2.50 per equity share.
  9. 9. MISSION, VISION AND VALUES OF TORRENT PHARMACEUTICALS LTD.
  10. 10. Risperidon e Venlafaxine Hydrochlori de Nicorandil Sertraline Hydrochlo ride Lamotrigi ne Nebivolol Hydrochlo ride API’S MANUFACTURED
  11. 11. Ormeloxife n Hydrochlori de Ropinarole Hydrochlori de Duloxetine Hydrochlori de API’S MANUFACTURED
  12. 12. ANALYSIS OF PROFITS: Following Financial Reports are used for the analysis of profits of Torrent Pharmaceuticals Ltd. Quarter Ended June 2013 Quarter Ended September 2013 Quarter Ended December 2013 Quarter Ended March 2014 Quarter Ended June 2014 Quarter Ended September 2014 Quarter Ended December 2014
  13. 13. • Profit : Rs. 149 crores Quarter Ended June 2013 • Profit : Rs. 113 crores Quarter Ended September 2013 • Profit : Rs. 158 crores Quarter Ended December 2013
  14. 14. • Profit : Rs. 224 crores Quarter Ended March 2014 • Profit : Rs. 256 crores Quarter Ended June 2014 • Profit : Rs. 198 crores Quarter Ended September 2014 • Profit : Rs. 167 crores Quarter Ended December 2014
  15. 15. MEASURES OF CENTRAL TENDENCIES:  A measure of central tendency is a single value that attempts to describe a set of data by identifying the central position within that set of data.  As such, measures of central tendency are sometimes called measures of central location.  They are also classed as summary statistics.  The mean (often called the average) is most likely the measure of central tendency that you are most familiar with, but there are others, such as the median and the mode.
  16. 16. • The mean is equal to the sum of all the values in the data set divided by the number of values in the data set. Mean: • total no. of sample and ‘X’ correspond to the observed valued. Formula of mean is:
  17. 17. • The median is the middle score for a set of data. • When there is an odd number of numbers, the median is simply the middle number. Median: • Where ‘n’ is the number of samples Formula of Median is:
  18. 18. • Mode of a set of data is the number with the highest frequency. Mode: • A statistic used as a measure of the dispersion or variation in a distribution or set of data, equal to the square root of the arithmetic mean of the squares of the deviations from the arithmetic mean. Standard Deviation:
  19. 19. Formula of Standard Deviation is:
  20. 20. • => 149+113+158+224+256+198+167 7 => 1265 7 => 180.71 Therefore, the mean profit of Torrent Pharmaceuticals Ltd. in 7 quarters is Rs. 180.71 crores. • Profit : Rs. 149 crores Quarter Ended June 2013 • Profit : Rs. 113 crores Quarter Ended September 2013 • Profit : Rs. 158 crores Quarter Ended December 2013 •Profit : Rs. 224 crores Quarter Ended March 2014 •Profit : Rs. 256 crores Quarter Ended June 2014 •Profit : Rs. 198 crores Quarter Ended September 2014 •Profit : Rs. 167 crores Quarter Ended December 2014
  21. 21. • Data in ascending order : 113,149,158,167,198,224,256 • [(n+1)/2]th data • [ (7+1)/2]th = 4th observation • 167 (Rs. in crores) Therefore, the Median is Rs. 167 crores. • Profit : Rs. 149 crores Quarter Ended June 2013 • Profit : Rs. 113 crores Quarter Ended September 2013 • Profit : Rs. 158 crores Quarter Ended December 2013 •Profit : Rs. 224 crores Quarter Ended March 2014 •Profit : Rs. 256 crores Quarter Ended June 2014 •Profit : Rs. 198 crores Quarter Ended September 2014 •Profit : Rs. 167 crores Quarter Ended December 2014
  22. 22. • The mode of a set of data is the number with highest frequency, here there is no repetition. Therefore, there is no Mode. • Profit : Rs. 149 crores Quarter Ended June 2013 • Profit : Rs. 113 crores Quarter Ended September 2013 • Profit : Rs. 158 crores Quarter Ended December 2013 •Profit : Rs. 224 crores Quarter Ended March 2014 •Profit : Rs. 256 crores Quarter Ended June 2014 •Profit : Rs. 198 crores Quarter Ended September 2014 •Profit : Rs. 167 crores Quarter Ended December 2014
  23. 23. Therefore, the standard deviation is Rs. 48.53 crores. • Profit : Rs. 149 crores Quarter Ended June 2013 • Profit : Rs. 113 crores Quarter Ended September 2013 • Profit : Rs. 158 crores Quarter Ended December 2013 •Profit : Rs. 224 crores Quarter Ended March 2014 •Profit : Rs. 256 crores Quarter Ended June 2014 •Profit : Rs. 198 crores Quarter Ended September 2014 •Profit : Rs. 167 crores Quarter Ended December 2014
  24. 24. BUSINESS IMPLICATION:  Torrent Pharmaceuticals Ltd. have average of Rs. 180.71 crores of profit after the calculation.  Torrent Pharmaceuticals Ltd. highest profits has been Rs. 256 crores while lowest profit has been Rs. 113 crores.
  25. 25. THANK YOU Reference: http://www.torrentpharma.com

×